0001721349-17-000002.txt : 20171115 0001721349-17-000002.hdr.sgml : 20171115 20171114184642 ACCESSION NUMBER: 0001721349-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171115 DATE AS OF CHANGE: 20171114 EFFECTIVENESS DATE: 20171115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PreveCeutical Medical Inc. CENTRAL INDEX KEY: 0001721349 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-298750 FILM NUMBER: 171203423 BUSINESS ADDRESS: STREET 1: 1177 WEST HASTINGS STREET, SUITE 2200 CITY: VANCOUVER STATE: A1 ZIP: V6E 2K3 BUSINESS PHONE: (604)416-7777 MAIL ADDRESS: STREET 1: 1177 WEST HASTINGS STREET, SUITE 2200 CITY: VANCOUVER STATE: A1 ZIP: V6E 2K3 D 1 primary_doc.xml X0708 D LIVE 0001721349 PreveCeutical Medical Inc. 1177 WEST HASTINGS STREET Suite 2200 VANCOUVER A1 BRITISH COLUMBIA, CANADA V6E 2K3 (604)416-7777 BRITISH COLUMBIA, CANADA Carrara Exploration Corp. None Corporation true 2014 Stephen Van Deventer 1177 West Hastings Street Suite 2200 Vancouver A1 BRITISH COLUMBIA, CANADA V6E 2K3 Executive Officer Director Promoter Kimberly Van Deventer 1177 West Hastings Street Suite 2200 Vancouver A1 BRITISH COLUMBIA, CANADA V6E 2K3 Executive Officer Director Promoter Makarand Jawadekar 1177 West Hastings Street Suite 2200 Vancouver A1 BRITISH COLUMBIA, CANADA V6E 2K3 Executive Officer Director Greg S. Reid 1177 West Hastings Street Suite 2200 Vancouver A1 BRITISH COLUMBIA, CANADA V6E 2K3 Director Matthew Coltura 1177 West Hastings Street Suite 2200 Vancouver A1 BRITISH COLUMBIA, CANADA V6E 2K3 Director Shabira Rajan 1177 West Hastings Street Suite 2200 Vancouver A1 BRITISH COLUMBIA, CANADA V6E 2K3 Executive Officer Harendra Parekh 1177 West Hastings Street Suite 2200 Vancouver A1 BRITISH COLUMBIA, CANADA V6E 2K3 Executive Officer Nicole Goncalves-Krysinski 1177 West Hastings Street Suite 2200 Vancouver A1 BRITISH COLUMBIA, CANADA V6E 2K3 Executive Officer Other Health Care $1 - $1,000,000 06b false 2017-08-29 true true true true Each option entitles the holder to acquire one common share at an exercise price of Cdn$0.81 until August 29, 2019. false 0 142390 142390 0 The $142,390.00 may be received upon the exercise of stock options. U.S. dollar amounts are based on the Bank of Canada noon rate of exchange reported on August 29, 2017, which was Cdn$1.2515=USD$1.00. false 2 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false PreveCeutical Medical Inc. Shabira Rajan Shabira Rajan CFO and Controller 2017-11-13